Gabayka

Full prescribing information available at https://medinfo.roche.com/en/prescribing-information-finder.html or email [email protected].
For medical information queries and product quality complaints, please email: [email protected].
For suspected adverse drug reaction, please report to the Food and Drug Administration (FDA) at www.fda.gov.ph and to the Roche (Philippines) Inc. Local Safety Unit at [email protected].

At the first sign of any drug reaction, the patient should seek medical attention immediately.
If you want to know more about GabayKa app and website, kindly visit https://gabayka.com/.

This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, please report to the Food and Drug Administration (FDA) at www.fda.gov.ph and to Roche (Philippines) Inc. Local Safety Unit via email at [email protected].

This website is intended for the Philippines only.
Roche (Philippines) Inc. (hereinafter referred to as “Roche”) is committed to protecting your personal information. Please read more about our Privacy Notice here (https://www.roche.com/privacy-policy/). You are aware that Roche has a legal obligation to collect and report potential adverse events brought to its attention to Health Authorities. In such cases, your data will be processed with greatest care and diligence in accordance with specific GVP (pharmacovigilance) legislation, as described in the Privacy Policy related to pharmacovigilance https://www.roche.com/privacy-notice-pv-mi. Your data will not be used for
any other purpose. Roche reserves the right to moderate the contents of GabayKa app and website. At our sole discretion, Roche may review and delete posts, comments, or other feedback that do not comply with the terms of use of this site or local regulations.